Mass spectrometry-based proteomics and analyses of serum: a primer for the clinical investigator.
The vocabulary of proteomics and the swiftly-developing, technological nature of the field constitute substantial barriers to clinical investigators. In recent years, mass spectrometry has emerged as the most promising technique in this field. The purpose of this review is to introduce the field of mass spectrometry-based proteomics to clinical investigators, to explain many of the relevant terms, to introduce the equipment employed in this field, and to outline approaches to asking clinical questions using a proteomic approach. Examples of clinical applications of proteomic techniques are provided from the fields of cancer and vasculitis research, with an emphasis on a pattern recognition approach.
Fusaro
V A
VA
National Cancer Institute/Food & Drug Administration, Clinical Proteomics Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Stone
J H
JH
D001798:Blood Proteins / Q000032:analysis*; D006801:Humans; D013058:Mass Spectrometry / Q000379:methods* / Q000639:trends; D040901:Proteomics / Q000379:methods* / Q000639:trends; D012219:Rheumatology; D014657:Vasculitis / Q000503:physiopathology*
D001798:Blood Proteins